Skip to content

Metformin and vitamin B12

Metformin and Vitamin B12 Deficiency:risk, testing and monitoring.

Metformin can lower vitamin B12 in some people. The goal is not automatic supplementation; it is recognising when symptoms or risk factors justify testing and acting on the result.

People talking outdoors
Clinical author: Dr Stavroula Nikitopoulou · GMC 6092503
Patient information · Published

Metformin can lower vitamin B12, but not everyone needs the same monitoring.

Metformin is an established treatment for type 2 diabetes and is also used in some people at high risk of developing diabetes. The Medicines and Healthcare products Regulatory Agency (MHRA) states that metformin can commonly reduce vitamin B12 levels, with greater risk at higher doses, with longer treatment duration and when other risk factors for deficiency are present. [1]

NICE also lists metformin as a risk factor for vitamin B12 deficiency. That does not mean every person taking metformin has deficiency or should start a supplement without assessment. The useful question is whether symptoms, additional risk factors or blood results make deficiency plausible enough to test. [2]

Vitamin B12 matters for normal blood-cell formation and neurological function. Untreated deficiency can lead to anaemia and neurological symptoms, so persistent symptoms should not be dismissed as a routine medicine effect.

When should B12 be checked if you take metformin?

The MHRA advises testing vitamin B12 when deficiency is suspected, for example in someone with megaloblastic anaemia or new-onset neuropathy. It also advises considering periodic monitoring in people who have additional risk factors. [1]

Those risk factors can include a diet low in B12, autoimmune disease, gastrointestinal surgery, coeliac disease, medicines that also affect B12, or conditions that reduce absorption. NICE recommends using either total B12 or active B12 as the initial test for suspected deficiency in most adults. [2]

There is no single private-practice interval that can be responsibly applied to everyone. The reason for testing should be explicit: symptoms, risk profile, an abnormal blood count, or monitoring in a person whose risk has become higher.

Can B12 deficiency look like diabetic neuropathy?

Yes, there can be overlap. Vitamin B12 deficiency can cause pins and needles, numbness, weakness, balance problems and other neurological symptoms. Diabetes itself can also cause peripheral neuropathy. That is why new or worsening neurological symptoms in a person taking metformin should not automatically be labelled as one or the other without assessment. [1]

The pattern, examination, diabetes control, medicine history and laboratory results all matter. A person can also have more than one contributor at the same time.

New neurological symptoms deserve medical review.

Do not wait for a routine supplement discussion if numbness, weakness, balance problems or other neurological symptoms are new or worsening. Earlier diagnosis matters because neurological injury from B12 deficiency can become harder to reverse if treatment is delayed.

What happens if the B12 result is low?

Management depends on whether deficiency is confirmed, the likely cause, symptom severity and whether absorption is impaired. NICE gives separate treatment pathways depending on cause and clinical context rather than one universal supplement dose. [2]

The MHRA specifically advises that metformin can usually be continued while B12 deficiency is corrected, provided metformin remains tolerated and is not otherwise contraindicated. [1]

That is an important distinction: identifying a medicine-associated deficiency does not automatically mean the medicine should be stopped. The clinician should weigh the benefit of metformin against the deficiency risk and treat each issue appropriately.

How should B12 fit into diabetes care?

B12 is one part of the wider diabetes picture. Blood glucose control, kidney health, blood pressure, lipids, foot care and medicine review can all matter. A B12 result should not distract from those established parts of diabetes management.

If you already have diabetes and need a broader review, the diabetes management and metabolic health page explains Dr Stavy’s wider assessment route. The focus here is metformin and B12 risk.

Bring your metformin dose, how long you have taken it, other medicines and supplements, any previous B12 results and a short description of symptoms. That gives the clinician enough context to decide whether testing or repeat testing is proportionate.

What should you avoid doing?

  • Do not stop metformin because you read that it can lower B12.
  • Do not assume tingling or numbness must be B12 deficiency.
  • Do not start a high-dose supplement before clarifying whether deficiency is present and why.
  • Do not rely on one old B12 result if new symptoms have developed.
  • Do not let B12 monitoring replace routine diabetes care.

The safest approach is targeted: recognise the risk, test when there is a reason, treat confirmed deficiency appropriately and keep the diabetes treatment plan visible.

A practical way to review B12 risk on metformin

Start with the medicine list. Note the metformin dose and how long you have taken it. Add any other medicines that can affect vitamin B12 or the gut. Bring the same list to your diabetes review so the clinician can see the full picture.

Next, look at symptoms. Tiredness is common and has many causes, so it is not enough on its own to prove B12 deficiency. Pins and needles, numbness, a sore red tongue, mouth ulcers, pale or yellow skin, memory change or balance problems can add useful context. If new nerve symptoms are present, say when they began and whether they are getting worse.

Then look at other risks. A vegan or very low-animal-food diet, coeliac disease, autoimmune gastritis, previous stomach or bowel surgery and other medicines can all change the chance of deficiency. A person with several risks may need a different monitoring plan from someone with none.

Finally, decide what the test is for. If the result is low, the next step may be treatment and a search for the cause. If it is normal, the clinician may need to look for another reason for the symptoms. That is what makes the test useful.

How should a B12 result be interpreted?

A single result should not be read in isolation. The lab range, symptoms, blood count, diet and medicine history all matter. Some results are clearly low. Others sit near the edge of the range and may need another test or a different way of checking B12 status.

NICE gives a pathway for confirmed and uncertain results rather than treating every borderline value in the same way. The clinician may consider the likelihood of deficiency, whether symptoms fit and whether another cause is more likely. [2]

If treatment is started, the aim is not only to make the number rise. The clinician also needs to know whether symptoms improve, whether the cause is still present and whether long-term treatment is needed. A medicine-related risk may remain even after the first course of treatment.

Keep copies of old results. A trend can help, especially when the same question is being followed over time. But do not repeat tests simply to collect numbers. Repeat when the answer can change care.

What is the safest next step?

If you take metformin and feel well, keep taking it as prescribed. Make sure your usual diabetes reviews stay up to date.

If you have symptoms that could fit low B12, ask for a medical review. Bring your medicine list and old blood results. The clinician can decide if a B12 test is needed.

If B12 is low, ask why it is low and how it should be treated. Do not assume metformin is the only cause. More than one risk can be present.

What patients say about the consultation experience.

Reviews can describe communication and consultation experience. They do not prove that a test, supplement or treatment is effective.

Read patient reviews on Google

Individual reviews do not predict diagnosis, treatment response or outcome.

“patient, understanding and kind”

Google reviewer

“warm and compassionate bedside manner”

Google reviewer

“takes incredible care to get to know her patients”

Google reviewer

Two friends sharing lunch outdoors

Common questions

Does metformin cause vitamin B12 deficiency?

Metformin can reduce vitamin B12 levels, and the MHRA classifies this as a common adverse effect. Risk is higher with larger doses, longer treatment and other deficiency risk factors. That does not mean everyone taking metformin is deficient. Symptoms and individual risk determine when testing is useful.

How often should B12 be checked on metformin?

There is no single interval for everyone. The MHRA recommends testing when deficiency is suspected and considering periodic monitoring in people with risk factors. The interval should reflect dose, duration, symptoms, diet, gastrointestinal history and previous results rather than a fixed annual rule.

Can low B12 feel like diabetic neuropathy?

Yes. Both B12 deficiency and diabetic neuropathy can cause sensory symptoms such as pins and needles or numbness. New neurological symptoms deserve clinical review because more than one cause can be present, and B12 deficiency should not be missed simply because a person has diabetes.

Should I stop metformin if my B12 is low?

Do not stop metformin on your own. The MHRA advises continuing metformin while B12 deficiency is corrected when metformin remains tolerated and is not contraindicated. The prescriber should review the diabetes benefit, the severity of deficiency and any other treatment issues.

Should I take B12 supplements just because I take metformin?

Not automatically. Supplementation is appropriate when there is a recognised indication, but the form, dose and duration depend on the cause and severity of deficiency. Testing or clinical review is usually more useful than assuming every metformin user needs the same supplement.

What should I bring to a B12 review?

Bring your metformin dose and duration, other medicines and supplements, previous B12 or blood-count results, relevant gastrointestinal history and the symptoms you want assessed. A short timeline helps the clinician decide whether testing, treatment or another explanation needs priority.

Medical sources and further reading
  1. MHRA: Metformin and reduced vitamin B12 levels. Current UK medicines-safety advice on risk, testing and continuing metformin while deficiency is corrected.
  2. NICE NG239: Vitamin B12 deficiency. Lists metformin among B12-deficiency risk factors and provides diagnostic and management recommendations.

Treat the deficiency without losing sight of diabetes care.

A good review links symptoms, metformin exposure, B12 risk and the wider diabetes plan instead of treating one blood result in isolation.